Nanoform Finland Oyj

Chart & performance

D1W1MN

P/E

—

P/S

18.65

EPS

—

Div yield, %

—

Shrs. gr., 5y

8.66%

Rev. gr., 5y

38.86%

Revenues

+27.67%

Net income

-18m

L-23.60%

CFO

-18m

L-3.35%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Helsinki, Finland-based Nanoform Finland Oyj provides advanced nanotechnology and drug particle engineering solutions for the pharmaceutical sector across Europe and the United States. The company specializes in the production of nanoparticles, utilizing its exclusive "controlled expansion of supercritical solutions" technology, which aids its clients in their development processes. Nanoform was established in 2008.

URL

https://nanoform.com/

IPO date

Jun 04, 2020

Employees

158

Domiciled in

Incorporated in

Headquarters & legal address

Viikinkaari 4
00790 HELSINKI
HELSINKI FI-00790
FI

Valuation

Order:

Title EUR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title EUR in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT